Le Lézard
Classified in: Health
Subject: LAW

Qui Tam Lawsuit to Proceed Against Hospice Care Provider Care Alternatives


PHILADELPHIA, March 4, 2020 /PRNewswire/ -- Berger Montague is pleased to announce that the Third Circuit has overturned a previous ruling and will allow a qui tam case brought by Managing Shareholder Sherrie R. Savett, Shareholder Russell D. Paul, and co-counsel against Care Alternatives to continue. The case is United States of America and State of New Jersey ex rel. Victoria Drudging, et al. v. Care Alternatives.

Berger Montague and co-counsel Begelman & Orlow represent four former employees of Care Alternatives, a hospice care provider. The whistleblowers allege that patients were inappropriately certified for and given hospice care when there was no clinical information or documentation in the patients' charts supporting a prognosis of terminal illness.

Previously, the District Court had granted Care Alternatives' motion for summary judgment, applying a standard adopted by the 11th Circuit in a separate qui tam case (Aseracare) regarding the False Claims Act's falsity element. The 11th Circuit had ruled that a difference of medical expert opinion was not enough to show falsity and that additional evidence was required.

On March 4, 2020, the Third Circuit overturned the District Court's decision, rejecting its reasoning. The Third Circuit found that a subjective medical opinion may be false, and an expert's testimony challenging a physician's medical opinion is enough to create a genuine dispute of material fact for the jury to consider whether that medical opinion is false.

"This is a tremendous victory for the entire qui tam bar that preserves the viability of medical necessity cases under the False Claims Act," said Mr. Paul, who argued the case before the Third Circuit. "If the District Court opinion was not overturned, a battle of the experts would nearly always result in summary judgment for defendant." 

Berger Montague's Whistleblower, Qui Tam & False Claims Act Practice Group has represented whistleblowers in matters involving healthcare fraud, defense contracting fraud, IRS fraud, securities fraud, and commodities fraud, helping to return more than $3 billion to federal and state governments. In return, whistleblower clients retaining Berger Montague to represent them in state and federal courts have received more than $500 million in rewards.

Please Contact:

Russell D. Paul
Shareholder
Berger Montague
215-875-4601
[email protected] 
https://bergermontague.com 

SOURCE Berger Montague


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: